TD Cowen lowered the firm’s price target on P3 Health Partners (PIII) to 25c from 90c and keeps a Hold rating on the shares. The firm updated its model to reflect 3Q24 results. The model assumes the company requires a $100m capital raise in 2025 to support continued operating losses.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PIII: